VEUCX
Price
$34.03
Change
+$0.05 (+0.15%)
Updated
Jul 3 closing price
Net Assets
620.23M
VEURX
Price
$41.74
Change
-$0.04 (-0.10%)
Updated
Jul 3 closing price
Net Assets
32.38B
Interact to see
Advertisement

VEUCX vs VEURX

Header iconVEUCX vs VEURX Comparison
Open Charts VEUCX vs VEURXBanner chart's image
JPMorgan Europe Dynamic C
Price$34.03
Change+$0.05 (+0.15%)
VolumeN/A
Net Assets620.23M
Vanguard European Stock Investor
Price$41.74
Change-$0.04 (-0.10%)
VolumeN/A
Net Assets32.38B
VEUCX vs VEURX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VEUCX vs. VEURX commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is VEUCX is a Buy and VEURX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VEURX has more cash in the bank: 32.4B vs. VEUCX (620M). VEURX (2.81) and VEUCX (2.68) have matching dividends . VEUCX was incepted earlier than VEURX: VEUCX (27 years) vs VEURX (35 years). VEUCX (1.85) is less costly to investors than VEURX (0.24). VEUCX is a more actively managed with annual turnover of: 95.00 vs. VEURX (3.00). VEURX has a lower initial minimum investment than VEUCX: VEURX (0) vs VEUCX (1000). VEUCX annual gain was more profitable for investors over the last year : 22.10 vs. VEURX (15.13). VEUCX return over 5 years is better than : 85.87 vs. VEURX (53.04).
VEUCXVEURXVEUCX / VEURX
Total Expense Ratio1.740.24725%
Annual Report Gross Expense Ratio1.850.24771%
Fund Existence27 years35 years-
Gain YTD29.58922.381132%
Front LoadN/AN/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets620M32.4B2%
Annual Yield % from dividends2.682.8195%
Returns for 1 year22.1015.13146%
Returns for 3 years71.0347.94148%
Returns for 5 years85.8753.04162%
Returns for 10 years78.4050.88154%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
U26.131.85
+7.62%
Unity Software
RAPP12.040.24
+2.03%
Rapport Therapeutics Inc.
BEAM20.010.13
+0.65%
Beam Therapeutics
ELUT2.09-0.07
-3.24%
Elutia
NUWE0.20-0.02
-10.57%
Nuwellis Inc